Accuray Inc (ARAY)
1.63
-0.04
(-2.40%)
USD |
NASDAQ |
May 17, 16:00
1.635
0.00 (0.00%)
After-Hours: 20:00
Accuray Gross Profit (Quarterly): 29.07M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 29.07M |
December 31, 2023 | 35.90M |
September 30, 2023 | 39.49M |
June 30, 2023 | 37.68M |
March 31, 2023 | 38.72M |
December 31, 2022 | 42.97M |
September 30, 2022 | 34.60M |
June 30, 2022 | 43.02M |
March 31, 2022 | 34.78M |
December 31, 2021 | 42.63M |
September 30, 2021 | 39.52M |
June 30, 2021 | 43.73M |
March 31, 2021 | 39.54M |
December 31, 2020 | 40.83M |
September 30, 2020 | 35.40M |
June 30, 2020 | 39.74M |
March 31, 2020 | 39.13M |
December 31, 2019 | 37.90M |
September 30, 2019 | 32.94M |
June 30, 2019 | 45.93M |
March 31, 2019 | 40.47M |
December 31, 2018 | 38.38M |
September 30, 2018 | 37.88M |
June 30, 2018 | 47.98M |
March 31, 2018 | 36.25M |
Date | Value |
---|---|
December 31, 2017 | 39.36M |
September 30, 2017 | 38.11M |
June 30, 2017 | 43.18M |
March 31, 2017 | 35.42M |
December 31, 2016 | 31.39M |
September 30, 2016 | 31.34M |
June 30, 2016 | 37.30M |
March 31, 2016 | 44.94M |
December 31, 2015 | 42.57M |
September 30, 2015 | 33.90M |
June 30, 2015 | 40.45M |
March 31, 2015 | 38.66M |
December 31, 2014 | 38.49M |
September 30, 2014 | 27.80M |
June 30, 2014 | 38.45M |
March 31, 2014 | 39.70M |
December 31, 2013 | 38.17M |
September 30, 2013 | 26.48M |
June 30, 2013 | 27.28M |
March 31, 2013 | 20.05M |
December 31, 2012 | 26.63M |
September 30, 2012 | 23.68M |
June 30, 2012 | 36.49M |
March 31, 2012 | 36.11M |
December 31, 2011 | 40.24M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
29.07M
Minimum
Mar 2024
45.93M
Maximum
Jun 2019
38.68M
Average
39.31M
Median
Gross Profit (Quarterly) Benchmarks
Boston Scientific Corp | 2.647B |
Integer Holdings Corp | 109.84M |
ResMed Inc | 692.78M |
Glaukos Corp | 65.36M |
Perspective Therapeutics Inc | -- |